Skip to content
10-Q

Quarterly Report

CHAMPIONS ONCOLOGY, INC. CSBR

0001628280-24-040312

← back to feed
Filed
Sep 13, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Sep 10, 2024 13.59M sh
Stock Repurchased Q1 2025 · Jul 31, 2024 $0
Stock Repurchased Q1 2025 · Jul 31, 2023 $602K
Cash And Equivalents Q1 2025 · Jul 31, 2024 $2.89M
Cash And Equivalents Q1 2025 · Apr 30, 2024 $2.62M
Stockholders Equity Q1 2025 · Jul 31, 2024 −$332K
Stockholders Equity Q1 2025 · Apr 30, 2024 −$1.9M
Stockholders Equity Q1 2025 · Jul 31, 2023 $1.9M
Stockholders Equity Q1 2025 · Apr 30, 2023 $4.64M
Current Liabilities Q1 2025 · Jul 31, 2024 $19.16M
Current Liabilities Q1 2025 · Apr 30, 2024 $21.54M
Total Liabilities Q1 2025 · Jul 31, 2024 $25.27M
Total Liabilities Q1 2025 · Apr 30, 2024 $28.04M
Current Assets Q1 2025 · Jul 31, 2024 $13.18M
Current Assets Q1 2025 · Apr 30, 2024 $13.64M
Total Assets Q1 2025 · Jul 31, 2024 $24.93M
Total Assets Q1 2025 · Apr 30, 2024 $26.13M
Operating Cash Flow Q1 2025 · Apr 30, 2024 −$6.1M
Operating Cash Flow Q1 2025 · Jul 31, 2023 −$3.99M
Net Income Q1 2025 · Apr 30, 2024 −$7.3M
Net Income Q1 2025 · Jul 31, 2023 −$2.57M
Shares Diluted Q1 2025 · Jul 31, 2023 13.51M sh
Capex Q1 2025 · Jul 31, 2023 $668K
Eps Diluted Q1 2025 · Jul 31, 2023 −$0.19
Eps Basic Q1 2025 · Jul 31, 2023 −$0.19
Sga Expense Q1 2025 · Jul 31, 2023 $2.94M
Rd Expense Q1 2025 · Jul 31, 2023 $2.79M
Operating Income Q1 2025 · Jul 31, 2023 −$2.55M
Cost Of Revenue Q1 2025 · Jul 31, 2023 $7.68M
Revenue Q1 2025 · Jul 31, 2023 $12.56M